Barclays’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.1K | Sell |
18,447
-91,081
| -83% | -$307K | ﹤0.01% | 4225 |
|
|
2025
Q4 | $310K | Buy |
109,528
+10,163
| +10% | +$52.4K | ﹤0.01% | 4116 |
|
|
2025
Q3 | $692K | Sell |
99,365
-30,502
| -23% | -$215K | ﹤0.01% | 3604 |
|
|
2025
Q2 | $769K | Buy |
129,867
+46,093
| +55% | +$265K | ﹤0.01% | 3508 |
|
|
2025
Q1 | $535K | Sell |
83,774
-23,990
| -22% | -$231K | ﹤0.01% | 3490 |
|
|
2024
Q4 | $1.28M | Buy |
107,764
+15,462
| +17% | +$264K | ﹤0.01% | 3209 |
|
|
2024
Q3 | $2.56M | Buy |
92,302
+71,024
| +334% | +$1.78M | ﹤0.01% | 2648 |
|
|
2024
Q2 | $507K | Sell |
21,278
-26,764
| -56% | -$628K | ﹤0.01% | 3038 |
|
|
2024
Q1 | $846K | Sell |
48,042
-32,561
| -40% | -$480K | ﹤0.01% | 3246 |
|
|
2023
Q4 | $1.27M | Buy |
80,603
+62,120
| +336% | +$641K | ﹤0.01% | 3262 |
|
|
2023
Q3 | $159K | Sell |
18,483
-3,045
| -14% | -$21.6K | ﹤0.01% | 3398 |
|
|
2023
Q2 | $170K | Sell |
21,528
-3,898
| -15% | -$27.1K | ﹤0.01% | 3324 |
|
|
2023
Q1 | $189K | Buy |
25,426
+17,073
| +204% | +$170K | ﹤0.01% | 3821 |
|
|
2022
Q4 | $98.5K | Buy |
8,353
+7,049
| +541% | +$80.6K | ﹤0.01% | 4231 |
|
|
2022
Q3 | $12K | Sell |
1,304
-112,570
| -99% | -$1.36M | ﹤0.01% | 4224 |
|
|
2022
Q2 | $1.13M | Buy |
113,874
+110,171
| +2,975% | +$2.22M | ﹤0.01% | 2253 |
|
|
2022
Q1 | $128K | Sell |
3,703
-23,066
| -86% | -$749K | ﹤0.01% | 3675 |
|
|
2021
Q4 | $1.33M | Buy |
26,769
+17,756
| +197% | +$936K | ﹤0.01% | 2635 |
|
|
2021
Q3 | $414K | Buy |
9,013
+6,185
| +219% | +$245K | ﹤0.01% | 3282 |
|
|
2021
Q2 | $84K | Sell |
2,828
-14,440
| -84% | -$295K | ﹤0.01% | 3913 |
|
|
2021
Q1 | $352K | Buy |
17,268
+2,944
| +21% | +$62.1K | ﹤0.01% | 3407 |
|
|
2020
Q4 | $239K | Buy |
14,324
+4,993
| +54% | +$65.6K | ﹤0.01% | 3665 |
|
|
2020
Q3 | $102K | Sell |
9,331
-1,867
| -17% | -$14.8K | ﹤0.01% | 4239 |
|
|
2020
Q2 | $73K | Buy |
+11,198
| New | +$71.9K | ﹤0.01% | 4717 |
|
|
2019
Q4 | – | Sell |
-109
| Closed | -$1K | – | 6325 |
|
|
2019
Q3 | $1K | Buy |
109
+93
| +581% | +$591 | ﹤0.01% | 6573 |
|
|
2019
Q2 | $0 | Buy |
+16
| New | +$73 | ﹤0.01% | 6925 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 6947 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | +$5 | ﹤0.01% | 7036 |
|
|
2016
Q2 | – | Sell |
-9,884
| Closed | -$40K | – | 6310 |
|
|
2016
Q1 | $40K | Sell |
9,884
-21,391
| -68% | -$97K | ﹤0.01% | 4896 |
|
|
2015
Q4 | $188K | Sell |
31,275
-20,920
| -40% | -$145K | ﹤0.01% | 3948 |
|
|
2015
Q3 | $366K | Buy |
52,195
+23,950
| +85% | +$174K | ﹤0.01% | 3629 |
|
|
2015
Q2 | $169K | Buy |
28,245
+28,073
| +16,322% | +$192K | ﹤0.01% | 4261 |
|
|
2015
Q1 | $2K | Sell |
172
-148
| -46% | -$1.12K | ﹤0.01% | 6850 |
|
|
2014
Q4 | $2K | Buy |
+320
| New | +$2.72K | ﹤0.01% | 7115 |
|
|
2014
Q3 | – | Sell |
-1,083,445
| Closed | -$11.9M | – | 7641 |
|
|
2014
Q2 | $11.9M | Buy |
+1,083,445
| New | +$11.8M | 0.01% | 1022 |
|
Other funds holding ASPN
KL
OCMI
NIM
VCM
GKFF
GS
RHJA
Barclays's ASPN Position: Q1 2026 in Review
Barclays reduced its Aspen Aerogels (ASPN) stake by 83% in Q1 2026, selling an estimated $307K and leaving 18,447 shares worth $63.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4225.
Barclays first reported a position in ASPN in Q2 2014 and has held it in 34 quarters since. The position peaked at $11.9M in Q2 2014. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- Barclays held 18,447 shares of Aspen Aerogels worth $63.1K as of Q1 2026.
- Barclays sold 91,081 Aspen Aerogels shares in Q1 2026, an estimated $307K.
- Aspen Aerogels made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4225 holding.
- Barclays first reported a position in Aspen Aerogels in Q2 2014 and has held it in 34 quarters since.
- Barclays's Aspen Aerogels position peaked at $11.9M in Q2 2014.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.